Liquidia (LQDA) Shares Outstanding (Weighted Average) (2019 - 2026)

Liquidia (LQDA) recorded quarterly Shares Outstanding (Weighted Average) of $88.0 million in Q1 2026, up 186821.21% quarter-over-quarter from $47082.0 in Q4 2025, and up 3.33% on a YoY basis from $85.2 million in Q1 2025.

Liquidia (LQDA) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

Liquidia's Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $88.0 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 3.33% year-over-year to $88.0 million; the TTM figure through Mar 2026 stood at $88.0 million (up 3.33% YoY), while the FY2025 annual figure was $47082.0, down 99.94% from the prior year.
  • Shares Outstanding (Weighted Average) was $88.0 million for Q1 2026 at Liquidia, up from $47082.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $88.0 million in Q1 2026 to a low of $47082.0 in Q4 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $54.7 million across 5 years, with a median of $64.8 million in 2023.
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 132340.13% in 2025; the steepest drop was 99.94% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $61.0 million in 2022, then rose by 6.62% to $65.0 million in 2023, then grew by 21.1% to $78.7 million in 2024, then tumbled by 99.94% to $47082.0 in 2025, then surged by 186821.21% to $88.0 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $88.0 million (Q1 2026), $47082.0 (Q4 2025), and $85.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 228.36 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 88.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 88.01 Mn
Dec 31, 2025 47,082.00
Sep 30, 2025 85.70 Mn
Jun 30, 2025 85.59 Mn
Mar 31, 2025 85.17 Mn
Dec 31, 2024 78.71 Mn
Sep 30, 2024 250,000.00
Jun 30, 2024 64,624.00
Mar 31, 2024 75.39 Mn
Dec 31, 2023 64.99 Mn
Sep 30, 2023 64.86 Mn
Jun 30, 2023 64.79 Mn
Mar 31, 2023 250,000.00
Dec 31, 2022 60.96 Mn
Sep 30, 2022 59.75 Mn
Jun 30, 2022 62.18 Mn
Mar 31, 2022 52.47 Mn
Dec 31, 2021 49.68 Mn
Sep 30, 2021 52.08 Mn
Jun 30, 2021 47.17 Mn